Back to resultsBLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
Primary Purpose
Bladder Cancer, Diabetes
Status
Completed
Phase
Early Phase 1
Locations
Ghana
Study Type
Interventional
Intervention
metformin
Sponsored by
About this trial
This is an interventional screening trial for Bladder Cancer focused on measuring pathology
Eligibility Criteria
Inclusion Criteria:
- 150 people attending diabetic clinic
Exclusion Criteria:
Sites / Locations
- Universty of Capecoast
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
No Intervention
Arm Label
metformin
not on metformin
Arm Description
metformin 500mg
Outcomes
Primary Outcome Measures
Number of diabetic patients on metformin therapy
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02505516
Brief Title
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
Official Title
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS ON METFORMIN THERAPY IN A WEST AFRICA SUB-REGION
Study Type
Interventional
2. Study Status
Record Verification Date
July 2015
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
January 2014 (Actual)
Study Completion Date
February 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
UFUOMA MILLER FAKPOR
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
patients om metformin from diabetic clinic were checked for bladder cancer
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bladder Cancer, Diabetes
Keywords
pathology
7. Study Design
Primary Purpose
Screening
Study Phase
Early Phase 1
Interventional Study Model
Single Group Assignment
Masking
Participant
Allocation
Randomized
Enrollment
150 (Actual)
8. Arms, Groups, and Interventions
Arm Title
metformin
Arm Type
Placebo Comparator
Arm Description
metformin 500mg
Arm Title
not on metformin
Arm Type
No Intervention
Intervention Type
Other
Intervention Name(s)
metformin
Other Intervention Name(s)
glucophage
Primary Outcome Measure Information:
Title
Number of diabetic patients on metformin therapy
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
86 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
150 people attending diabetic clinic
Exclusion Criteria:
Facility Information:
Facility Name
Universty of Capecoast
City
Cape Coast
Country
Ghana
12. IPD Sharing Statement
Learn more about this trial
BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS
We'll reach out to this number within 24 hrs